Hep C treatment moves into primary care 16 Feb 2012 0 comments People with hepatitis C are being treated by “hepatitis C integration nurses “ in primary care and a Melbourne addiction clinic, in a scheme developed after patients were found to be unlikely to attend public hospital liver clinics.
Promising drug trial in narcotic bowel syndrome 16 Feb 2012 0 comments Management of a curious and debilitating bowel condition is a step closer after a small Australian trial of the drug methylnatrexone reported promising results.
Gut-directed hypnotherapy works for years 16 Feb 2012 0 comments The benefits of hypnotherapy in treating children with irritable bowel syndrome or functional abdominal pain last for years, say the authors of the longest follow-up study yet.
Many cancers linked to Lynch syndrome 16 Feb 2012 0 comments People with the inherited Lynch syndrome face a much greater risk for pancreatic and colorectal cancer than the general population, new Australian research confirms.
5-ASA combination best for ulcerative colitis 8 Feb 2012 0 comments A combined oral and topical 5-aminosalicylates (5-ASA) regimen is more effective than oral treatment alone in inducing remission of ulcerative colitis (UC), a new meta-analysis shows.
Research questions travel risk for IBD patients 8 Feb 2012 0 comments The tendency of IBD patients to avoid travelling due to fear of enteric illness may be unfounded, say the authors of the first research of its kind.
H. pylori linked to type 2 diabetes 8 Feb 2012 0 comments Older people infected with Helicobacter pylori could be at increased risk of developing type 2 diabetes compared with those with no sign of the infection, according to new research.
Antidepressant use common in IBD 1 Feb 2012 0 comments Antidepressant use is common among people with inflammatory bowel disease, with almost 30% of patients having taken them and many using them long term.
Metformin may reduce pancreatic cancer risk in women only 1 Feb 2012 0 comments The diabetes drug Metformin, previously linked with reduced pancreatic cancer risk, has been found by a new large-scale study to only lower risk in women.
Infliximab gets the (foot) drop on patient 25 Jan 2012 0 comments Clinicians should be aware of peripheral neuropathy as a rare complication of anti- TNF therapy, experts warn.